Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-004481-16Phase 2Completed
Phase 2, randomised, single-blind trial of SB-705498 in odontalgia (4 arms), sponsored by GSK. Primary endpoint: Weighted mean change from baseline in pain intensity over 10 hours post-dose. Started Oct 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-004481-16.